Eithan Galun

Title: Eithan Galun: Innovator in Metabolic and Viral Disease Treatments

Introduction

Eithan Galun is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the fields of metabolic and viral disease treatments. With a total of 2 patents, his work focuses on innovative methods and compositions that address critical health issues.

Latest Patents

Galun's latest patents include groundbreaking inventions such as modulators of orphan nuclear receptors for non-alcoholic steatohepatitis (NASH) and other metabolic disorders. These patents disclose compounds, compositions, and methods for modulating retinoic acid receptor-like orphan receptors (ROR) and associated diseases. Additionally, he has developed methods for the treatment or prophylaxis of metabolic disorders, liver disorders, immune disorders, central nervous system disorders, and cancer. Another significant patent involves methods of preventing viral replication, particularly targeting the hepatitis B virus. This invention introduces an antisense oligonucleotide into a target cell, which is complementary to an mRNA that encodes part or all of the terminal protein region of the viral polymerase.

Career Highlights

Eithan Galun is affiliated with The General Hospital Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating complex diseases that affect millions of people worldwide.

Collaborations

Some of his notable coworkers include Hubert E Blum and Tsanyang Jake Liang, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Eithan Galun's innovative work in the field of metabolic and viral disease treatments showcases his commitment to advancing medical science. His patents reflect a deep understanding of complex biological processes and a dedication to improving patient outcomes.